Jessica Zucman-Rossi professeur d'oncologie médicale à l'université Paris-Descartes
Zucman-Rossi, Jessica, 1964-...., spécialiste en cancérologie
![Sudoc [ABES], France](/viaf/images/flags/SUDOC.png "Sudoc [ABES], France")
Zucman-Rossi, Jessica
VIAF ID: 191676877 (Personal)
Permalink: http://viaf.org/viaf/191676877
Preferred Forms
4xx's: Alternate Name Forms (5)
Works
| Title | Sources |
|---|---|
| Analyse génomique et transcriptomique des tumeurs hépatocellulaires de l’enfant. |
|
| Application of bioinformatics approaches to improve efficacy and safety of AAV gene therapy strategies for GSDIa and GSDIII |
|
| Caractérisation génomique des tumeurs pédiatriques du foie et identification de nouveaux biomarqueurs moléculaires prédictifs de la réponse thérapeutique |
|
| Characterization of molecular markers associated with a high risk of metastasis development in uveal melanoma patients. |
|
| CLONAGE ET CARACTERISATION DES TRANSLOCATIONS CHROMOSOMIQUES DES TUMEURS D'EWING ET DES MELANOMES MALINS DES PARTIES MOLLES IMPLIQUANT LE GENE EWS |
|
| CLONING AND CHARACTERIZATION OF THE EWING'S SARCOMA AND MALIGNANT MELANOMA OF SOFT PARTS TRANSLOCATION BREAKPOINTS. |
|
| Dérégulation du complexe BAF dans les sarcomes épithélioïdes et leur variants génétiques |
|
| Développement et caractérisation de modèles précliniques de carcinomes hépatocellulaires pour l'évaluation de la réponse thérapeutique et l'étude des mécanismes de l'hépatocarcinogenèse |
|
| Etude du rôle de l'inactivation d'HNF1α dans la tumorigenèse hépatique |
|
| From the editor's desk ... |
|
| Genetics of Ocular Melanomas. |
|
| Genomic Profiling Reveals Alternative Genetic Pathways of Meningioma Malignant Progression Dependent on the UnderlyingNF2Status |
|
| Genotype-phenotype correlation ofCTNNB1mutations reveals different ß-catenin activity associated with liver tumor progression |
|
| Identification des nouveaux déterminants génétiques prédisposant aux carcinomes hépatocellulaires. |
|
| Identification des voies de tumorigenèse impliquées dans le développement des tumeurs bénignes d'origine hépatocytaire |
|
| Identification of new mechanisms of carcinogenesis and new prognostic biomarkers in hepatocellular tumors. |
|
| Identification of tumorigenic pathways involved in the development of benign hepatocellular tumors. |
|
| Impact de la prise d'agonistes progestatifs sur les mécanismes de l'initiation et de la croissance tumorale des méningiomes |
|
| Integrative bioinformatics analysis of intra-tumoral heterogeneity in neuroblastoma at single cell level |
|
| Integrative characterization of oncogenesis and immune response in sarcoma |
|
| Kidney cancer: Single nucleotide polymorphisms in mRCC-is their time up? |
|
| KIF20A mRNA and its product MKlp2 are increased during hepatocyte proliferation and hepatocarcinogenesis |
|
| Lect2 Controls Inflammatory Monocytes to Constrain the Growth and Progression of Hepatocellular Carcinoma |
|
| The liver-specific microRNA-122*, the complementary strand of microRNA-122, acts as a tumor suppressor by modulating the p53/mouse double minute 2 homolog circuitry. |
|
| LKB1, gatekeeper of hepatocyte proliferation and genomic integrity. |
|
| Long Noncoding RNA NIHCOLE Promotes Ligation Efficiency of DNA Double-Strand Breaks in Hepatocellular Carcinoma |
|
| Macrotrabecular-massive hepatocellular carcinoma: A distinctive histological subtype with clinical relevance |
|
| Malignant transformation of a β-catenin inflammatory adenoma due to an S45 β-catenin-activating mutation present 12 years before. |
|
| Metalloproteinase meprin α regulates migration and invasion of human hepatocarcinoma cells and is a mediator of the oncoprotein Reptin |
|
| microRNA 193a-5p Regulates Levels of Nucleolar- and Spindle-Associated Protein 1 to Suppress Hepatocarcinogenesis |
|
| MicroRNA profiling in hepatocellular tumors is associated with clinical features and oncogene/tumor suppressor gene mutations |
|
| Molecular characterization of hepatocellular carcinoma related to hepatitis B virus. |
|
| Molecular Classification of Hepatocellular Adenoma Associates With Risk Factors, Bleeding, and Malignant Transformation |
|
| Molecular Classification of Malignant Pleural Mesothelioma: Identification of a Poor Prognosis Subgroup Linked to the Epithelial-to-Mesenchymal Transition |
|
| Molecular mechanisms and oncogenic consequences of Hepatitis B Virus integrations in liver tissues. |
|
| Molecular pathogenesis of focal nodular hyperplasia and hepatocellular adenoma |
|
| Molecular profiling of liver tumors: classification and clinical translation for decision making |
|
| Mutation of TCF1 encoding hepatocyte nuclear factor 1α in gynecological cancer |
|
| Mutation of TP53 gene is involved in carcinogenesis of hepatic undifferentiated (embryonal) sarcoma of the adult, in contrast with Wnt or telomerase pathways: an immunohistochemical study of three cases with genomic relation in two cases. |
|
| A new strategy to boost AAV-mediated gene therapy by engineering the ITR sequences. |
|
| Note of caution: Contaminations of hepatocellular cell lines. |
|
| NRF2/KEAP1 and Wnt/β-catenin in the multistep process of liver carcinogenesis in humans and rats. |
|
| Overexpression and role of the ATPase and putative DNA helicase RuvB-like 2 in human hepatocellular carcinoma |
|
| Overexpression of phosphatidylinositol 4-kinase type IIIα is associated with undifferentiated status and poor prognosis of human hepatocellular carcinoma. |
|
| Pas de titre traduit. |
|
| Personalized medicine in endometrial carcinoma : development of new prognostic and theranostic biomarkers. |
|
| PNPLA3 gene in liver diseases |
|
| The pro-oncogenic effect of the lncRNA H19 in the development of chronic inflammation-mediated hepatocellular carcinoma |
|
| Prognostic and theranostic impact of molecular subtypes and immune classifications in renal cell cancer (RCC) and colorectal cancer (CRC). |
|
| Proliferation Markers Are Associated with MET Expression in Hepatocellular Carcinoma and Predict Tivantinib Sensitivity In Vitro |
|
| Recurrent AAV2-related insertional mutagenesis in human hepatocellular carcinomas |
|
| Reply |
|
| RIPK1 Suppresses a TRAF2-Dependent Pathway to Liver Cancer. |
|
| Rôle de dipeptidyl peptidase-4 dans la régulation du trafic leucocytaire au cours du carcinome hépatocellulaire |
|
| Role of contrast-enhanced sonography in differentiation of subtypes of hepatocellular adenoma: correlation with MRI findings |
|
| The role of telomeres and telomerase in cirrhosis and liver cancer |
|
| Search for tumor suppressor genes implicated in human hepatic carcinogenesis. |
|
| Sex and acetazolamide effects on chemoreflex and periodic breathing during sleep at altitude |
|
| Similar tumor suppressor gene alteration profiles in asbestos-induced murine and human mesothelioma |
|
| Single nucleotide polymorphisms and risk of hepatocellular carcinoma in cirrhosis |
|
| Somatic mutations activating STAT3 in human inflammatory hepatocellular adenomas |
|
| Specific association between alcohol intake, high grade of differentiation and 4q34-q35 deletions in hepatocellular carcinomas identified by high resolution allelotyping |
|
| STAT3 mutations identified in human hematologic neoplasms induce myeloid malignancies in a mouse bone marrow transplantation model. |
|
| Stéatose hépatique non alcoolique : implication du stress de réplication dans la progression de la maladie |
|
| STUDY OF THE DIFFERENT GENETIC FORMS OF THE HEPATOCELLULAR ADENOMAS. |
|
| Study of the role of HNF1 alpha inactivation in hepatic tumorigenesis. |
|
| Synchronous hepatocellular carcinoma and Castleman's disease: the role of the interleukin-6-signaling pathway |
|
| Tissue metabolomics of hepatocellular carcinoma: tumor energy metabolism and the role of transcriptomic classification. |
|
| A TLR3 ligand reestablishes chemotherapeutic responses in the context of FPR1 deficiency |
|
| Toward understanding and exploiting tumor heterogeneity |
|
| [Towards a new diagnostic approach to benign hepatocytic nodules] |
|
| The transcriptomic G1-G6 signature of hepatocellular carcinoma in an Asian population: Association of G3 with microvascular invasion. |
|
| Trial Watch: Monoclonal antibodies in cancer therapy |
|
| Tumoral initiation mechanisms and biologic effects of progestin agonists on meningiomas. |
|
| Validation of VEGFR1 rs9582036 as predictive biomarker in metastatic clear-cell renal cell carcinoma patients treated with sunitinib |
|
| Le virus adéno-associé dans le foie : histoire naturelle de l'infection et conséquences sur le développement des tumeurs. |
|
| What's in a name? |
|
| When activated oncogene meets immunity: a fight to prevent liver tumor initiation |
|
| প্রত্যুত্তর |
|
